Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fucoidan Combined with Vonoprazan and Amoxicillin for H. pylori Eradication
NCT05461508Phase 2Recruiting
- Sponsor
- Nanjing First Hospital
- Start
- Oct 2022
- Primary completion
- Jun 2024
- Modality
- Polysaccharide, Nutraceutical
- Countries
- 1
01
Overview
A Phase 2 trial of fucoidan in Helicobacter pylori infection, sponsored by Nanjing First Hospital. Started Oct 2022; status: recruiting.
02
Drugs
fucoidan
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT05461508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05461508.